CCCC
Price
$2.60
Change
+$0.05 (+1.96%)
Updated
Aug 29 closing price
Capitalization
185.04M
61 days until earnings call
MGNX
Price
$1.77
Change
+$0.07 (+4.12%)
Updated
Aug 29 closing price
Capitalization
111.87M
73 days until earnings call
Interact to see
Advertisement

CCCC vs MGNX

Header iconCCCC vs MGNX Comparison
Open Charts CCCC vs MGNXBanner chart's image
C4 Therapeutics
Price$2.60
Change+$0.05 (+1.96%)
Volume$1.33M
Capitalization185.04M
MacroGenics
Price$1.77
Change+$0.07 (+4.12%)
Volume$854.85K
Capitalization111.87M
CCCC vs MGNX Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. MGNX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (CCCC: $2.60 vs. MGNX: $1.77)
Brand notoriety: CCCC and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 80% vs. MGNX: 96%
Market capitalization -- CCCC: $185.04M vs. MGNX: $111.87M
CCCC [@Biotechnology] is valued at $185.04M. MGNX’s [@Biotechnology] market capitalization is $111.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while MGNX’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 5 bearish.
  • MGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -0.38% price change this week, while MGNX (@Biotechnology) price change was +4.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($185M) has a higher market cap than MGNX($112M). CCCC YTD gains are higher at: -27.778 vs. MGNX (-45.538). MGNX has higher annual earnings (EBITDA): -26.91M vs. CCCC (-109.63M). CCCC has more cash in the bank: 215M vs. MGNX (176M). MGNX has less debt than CCCC: MGNX (37.2M) vs CCCC (62.9M). MGNX has higher revenues than CCCC: MGNX (164M) vs CCCC (34.2M).
CCCCMGNXCCCC / MGNX
Capitalization185M112M165%
EBITDA-109.63M-26.91M407%
Gain YTD-27.778-45.53861%
P/E RatioN/AN/A-
Revenue34.2M164M21%
Total Cash215M176M122%
Total Debt62.9M37.2M169%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCMGNX
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 6 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDVSF14.05N/A
N/A
Bidvest Group Ltd.
CAJFF29.30N/A
N/A
Canon, Inc.
ETST0.20N/A
N/A
Earth Science Tech, Inc.
VBIZF0.31N/A
N/A
Viva Biotech Holdings
KSEZ0.09N/A
-5.00%
Kinetic Seas, Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+1.96%
BEAM - CCCC
48%
Loosely correlated
-2.91%
SYRE - CCCC
44%
Loosely correlated
-1.38%
OCUL - CCCC
44%
Loosely correlated
-2.48%
MGNX - CCCC
44%
Loosely correlated
+4.12%
KYMR - CCCC
44%
Loosely correlated
-1.32%
More